AF
ATNM icon

Allworth Financial’s Actinium Pharmaceuticals ATNM Stock Holding History

Allworth Financial’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-120
Closed -$1K – 1333
2020
Q3 		$1K Hold
120
– – ﹤0.01% 1063
2020
Q2 		$1K Buy
+120
New +$909 ﹤0.01% 1067

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allworth Financial's ATNM Position: Q4 2020 in Review

Allworth Financial sold out of Actinium Pharmaceuticals (ATNM) in Q4 2020, closing a stake of 120 shares — an estimated $1K sold.

Allworth Financial first reported a position in ATNM in Q2 2020 and held it in 2 quarters. The position peaked at $1K in Q3 2020. 48 funds tracked by Wall St. Rank hold ATNM as of Q4 2020.

  • Allworth Financial reported no remaining Actinium Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Allworth Financial sold 120 Actinium Pharmaceuticals shares in Q4 2020, an estimated $1K.
  • Allworth Financial first reported a position in Actinium Pharmaceuticals in Q2 2020 and held it in 2 quarters.
  • Allworth Financial's Actinium Pharmaceuticals position peaked at $1K in Q3 2020.
  • 48 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2020.

Based on Allworth Financial's 13F filing for Q4 2020, filed 26 Jan 2021.